FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to medicine and pharmacology, and concerns a method of introducing a polypeptide containing an epidermal growth factor like (EGF-like) domain containing introducing the above peptide for at least two days after a neurological damage, as well as after a mammal reaches a full volume of the ischemic cell death following the damage.
EFFECT: invention provides treating the neurological damage in the post-acute or chronic period following the neurological damage to limit the cerebral damage, functional recovery and/or recovery enhancement following the neurological damage.
15 cl, 19 ex, 18 dwg
Title |
Year |
Author |
Number |
COMPOSITIONS AND METHODS FOR TREATMENT DURING NON-ACUTE PERIODS FOLLOWING NEUROLOGICAL CNS DAMAGE |
2013 |
- Kadzhano Entoni
- Ajasi Dzhennifer
|
RU2646507C2 |
THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE |
2014 |
- Kadzhano Entoni
- Ganguli Anindita
- Ajasi Dzhennifer
- Perri Tom
|
RU2698090C2 |
APPLICATION OF PEPTIDE GGF2 IN TREATMENT OR PREVENTION OF HEART FAILURE IN MAMMALS |
2009 |
- Kadzhano Ehntoni
- Ganguli Anindita
- Ajasi Dzhennifer
- Pehrri Tom
|
RU2536938C2 |
THERAPEUTIC DOSING OF NEUREGULIN OR ITS SUB-SEQUENCE FOR TREATING OR PREVENTING HEART FAILURE |
2019 |
- Kadzhano, Entoni
- Ganguli, Anindita
- Ajasi, Dzhennifer
- Perri, Tom
|
RU2719199C1 |
METHOD FOR ACHIEVING DESIRED GLIAL GROWTH FACTOR 2 PLASMA LEVELS |
2014 |
- Kim Khaesun
- Kadzhano Entoni O.
|
RU2687097C2 |
METHOD OF PROVIDING REQUIRED LEVELS OF GLIAL GROWTH FACTOR 2 IN PLASMA |
2009 |
- Kim Khaesun
- Kadzhano Ehntoni O.
|
RU2530650C2 |
ACTIVE SOLUBLE ISOFORMS OF NEUREGULIN, WHICH CARRY POST-TRANSLATION MODIFICATIONS |
2008 |
|
RU2491955C2 |
USING NEUREGULIN FOR TREATING PERIPHERAL NERVES INJURY |
2018 |
- Caggiano, Anthony, O.
- Bella, Anthony, J.
- Iaci, Jennifer, F.
|
RU2715908C2 |
USING NEUREGULIN FOR TREATING PERIPHERAL NERVE INJURY |
2010 |
- Kadzhano Ehntoni O.
- Bella Ehntoni Dzh.
- Ajasi Dzhennifer F.
|
RU2575570C2 |
METHODS OF NEURAL DISORDER TREATMENT WITH USING HEMATOPOIETIC GROWTH FACTORS |
2003 |
- Shebitts Vol'F-Rjudiger
- Shnajder Armin
- Krjuger Karola
- Zommer Klemens
- Shvab Shtefan
- Koll'Mar Rajner
- Maurer Martin
- Veber Daniehla
- Gassler Nikolaus
|
RU2353385C2 |